Evidence map›Paper›PMID 33799867›Full record

ArticleMembranes2021

Development of an In Vitro Airway Epithelial-Endothelial Cell Culture Model on a Flexible Porous Poly(Trimethylene Carbonate) Membrane Based on Calu-3 Airway Epithelial Cells and Lung Microvascular Endothelial Cells.

Thijs Pasman, Danielle Baptista, Sander van Riet, Roman K Truckenmüller, Pieter S Hiemstra, Robbert J Rottier, Naomi M Hamelmann, Jos M J Paulusse, Dimitrios Stamatialis, André A Poot

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Development of 3D Primary Co-Culture Models of the Human Airway.International journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Thijs PasmanTechnical Medical (TechMed) Centre, Department of Biomaterials Science and Technology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.
Danielle BaptistaDepartment of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0003-1871-4960
Sander van RietLeiden University Medical Centre, Department of Pulmonology, Leiden University, 2300 RC Leiden, The Netherlands.
Roman K TruckenmüllerDepartment of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, The Netherlands.
Pieter S HiemstraLeiden University Medical Centre, Department of Pulmonology, Leiden University, 2300 RC Leiden, The Netherlands.ORCID 0000-0002-0238-5982
Robbert J RottierErasmus MC-Sophia Children's Hospital, Departments of Pediatric Surgery and Cell Biology, 3000 CB Rotterdam, The Netherlands.ORCID 0000-0002-9291-4971
Naomi M HamelmannDepartment of Biomolecular NanoTechnology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0002-7126-4818
Jos M J PaulusseDepartment of Biomolecular NanoTechnology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0003-0697-7202
Dimitrios StamatialisTechnical Medical (TechMed) Centre, Department of Biomaterials Science and Technology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0002-2298-2442
André A PootTechnical Medical (TechMed) Centre, Department of Biomaterials Science and Technology, Faculty of Science and Technology, University of Twente, 7522 NB Enschede, The Netherlands.
University of Twente · NLLeiden University · NLMaastricht University · NLErasmus MC - Sophia Children’s Hospital · NL

Funding

Lung Foundation Netherlands 6.1.14.010
6 · The paper itself

Abstract

Due to the continuing high impact of lung diseases on society and the emergence of new respiratory viruses, such as SARS-CoV-2, there is a great need for in vitro lung models that more accurately recapitulate the in vivo situation than current models based on lung epithelial cell cultures on stiff membranes. Therefore, we developed an in vitro airway epithelial-endothelial cell culture model based on Calu-3 human lung epithelial cells and human lung microvascular endothelial cells (LMVECs), cultured on opposite sides of flexible porous poly(trimethylene carbonate) (PTMC) membranes. Calu-3 cells, cultured for two weeks at an air-liquid interface (ALI), showed good expression of the tight junction (TJ) protein Zonula Occludens 1 (ZO-1). LMVECs cultured submerged for three weeks were CD31-positive, but the expression was diffuse and not localized at the cell membrane. Barrier functions of the Calu-3 cell cultures and the co-cultures with LMVECs were good, as determined by electrical resistance measurements and fluorescein isothiocyanate-dextran (FITC-dextran) permeability assays. Importantly, the Calu-3/LMVEC co-cultures showed better cell viability and barrier function than mono-cultures. Moreover, there was no evidence for epithelial- and endothelial-to-mesenchymal transition (EMT and EndoMT, respectively) based on staining for the mesenchymal markers vimentin and α-SMA, respectively. These results indicate the potential of this new airway epithelial-endothelial model for lung research. In addition, since the PTMC membrane is flexible, the model can be expanded by introducing cyclic stretch for enabling mechanical stimulation of the cells. Furthermore, the model can form the basis for biomimetic airway epithelial-endothelial and alveolar-endothelial models with primary lung epithelial cells.

Indexed as

barrier functionCalu-3 cellsin vitro lung modelsLMVECsmembranesPTMC

Identifiers

PMID33799867
PMCPMC8001677
OpenAlexW3135306912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.